scispace - formally typeset
L

Lesley C. Wright

Researcher at Ludwig Institute for Cancer Research

Publications -  14
Citations -  592

Lesley C. Wright is an academic researcher from Ludwig Institute for Cancer Research. The author has contributed to research in topics: Nuclear magnetic resonance spectroscopy & Phospholipid. The author has an hindex of 11, co-authored 14 publications receiving 580 citations.

Papers
More filters
Journal ArticleDOI

Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model

TL;DR: In this paper, neutral lipid domains are intercalated with the bilayer lipid of the plasma membrane and a functional role for these neutral lipids is also proposed based on plasma membrane alterations which occur with cellular stimulation, with the acquisition of resistance to anti-cancer drugs, and in metastatic cells.
Journal ArticleDOI

High-resolution proton nuclear magnetic resonance analysis of metastatic cancer cells

TL;DR: In this paper, high-resolution proton nuclear magnetic resonance (NMR) studies of intact cancer cells revealed differences between cells with the capacity to metastasize and those that produce locally invasive tumors.
Journal ArticleDOI

Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts

TL;DR: Plasma membranes purified 32‐ to 45‐fold were isolated from leukaemic T‐lymphoblasts, both sensitive and resistant to the Vinca alkaloid vinblastine, and on development of drug resistance there was a very significant elevation of ether lipid content.
Journal ArticleDOI

Proteolipid identified by magnetic resonance spectroscopy in plasma of a patient with borderline ovarian tumour.

TL;DR: The long T2 relaxation value in the MRS profile, found in isolated proteolipid and unfractionated plasma and serum of other patients with carcinoma of the ovary and colon, provides a non-invasive method of assaying for cancer.
Journal ArticleDOI

Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer

TL;DR: An increase in the plasma levels of apoprotein B‐containing lipoproteins is the basis of the magnetic resonance (MR) test for cancer, but plasma from patients with hyperlipidemia unrelated to cancer also show narrow MR line widths and are therefore a confounding variable.